Riddle Valerie D 4
4 · PHARMATHENE, INC · Filed May 25, 2011
Insider Transaction Report
Form 4
Riddle Valerie D
VP, Medical Director
Transactions
- Sale
Common Stock, $0.0001 par value per share
2011-05-23$3.68/sh−3,438$12,652→ 53,323 total - Exercise/Conversion
Option to purchase
2011-05-23−3,438→ 24,065 totalExercise: $2.46Exp: 2019-01-21→ Common Stock (3,438 underlying) - Exercise/Conversion
Common Stock, $0.0001 par value per share
2011-05-23$2.46/sh+3,438$8,457→ 56,761 total - Sale
Common Stock, $0.0001 par value per share
2011-05-23$3.63/sh−5,353$19,430→ 49,790 total
Footnotes (3)
- [F1]The transactions reported hereon have been effected pursuant to the Reporting Person's 10b5-1 Plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.628 to $3.633, inclusive.
- [F3]The option exercised is part of a January 21, 2009 grant of options to purchase an aggregate of 27,503 shares, which vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.